The Swiss Hepatitis C Cohort Study (SCCS)

被引：68

作者：

Prasad, Leonie

Spicher, Virginie Masserey

Zwahlen, Marcel

Rickenbach, Martin

Helbling, Beat

Negro, Francesco

机构：

[1] Dept Social & Prevent Med, Div Epidemiol & Biostat, CH-3012 Bern, Switzerland

[2] Swiss Fed Off Publ Hlth, Div Communicable Dis, Vaccinat Sect, CH-3003 Bern, Switzerland

[3] CHU Vaudois, CH-1011 Lausanne, Switzerland

[4] Stadtspital Waid, CH-8037 Zurich, Switzerland

[5] Hop Univ Geneve, Serv Gastroenterol & Hepatol, Pathol Clin, CH-1211 Geneva, Switzerland

来源：

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY | 2007年 / 36卷 / 04期

关键词：

D O I：

10.1093/ije/dym096

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

[No abstract available]

引用

页码：731 / 737

页数：7

共 16 条

[1] ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].

CHOO, QL ;

KUO, G ;

WEINER, AJ ;

OVERBY, LR ;

BRADLEY, DW ;

HOUGHTON, M .

SCIENCE, 1989, 244 (4902) :359-362

[2] Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study [J].

Egger, M ;

Hirschel, B ;

Francioli, P ;

Sudre, P ;

Wirz, M ;

Flepp, M ;

Rickenbach, M ;

Malinverni, R ;

Vernazza, P ;

Battegay, M ;

Bernasconi, E ;

Burgisser, P ;

Erb, P ;

Fierz, W ;

Grob, P ;

Gruninger, U ;

Jeannerod, L ;

Ledergerber, B ;

Luthy, R ;

Matter, L ;

Opravil, M ;

Paccaud, F ;

Perrin, L ;

Pichler, W ;

Piffaretti, GC ;

Rutschmann, O ;

Zanetti, G .

BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7117) :1194-1199

[3]

Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35

[4] THE SWISS HIV COHORT STUDY - RATIONALE, ORGANIZATION AND SELECTED BASE-LINE CHARACTERISTICS [J].

LEDERGERBER, B ;

VONOVERBECK, J ;

EGGER, M ;

LUTHY, R ;

BUCHER, H ;

ERB, P ;

MATTER, L ;

PICHLER, WJ ;

HIRSCHEL, B ;

PERRIN, L ;

FRANCIOLI, P ;

FREI, P ;

FIERZ, W ;

VERNAZZA, P ;

GROB, PJ ;

GUTZWILLER, F ;

HEUSSER, R ;

KNOPFLI, D ;

BUNDSCHU, B ;

HACHLER, I ;

MEISTER, T .

SOZIAL-UND PRAVENTIVMEDIZIN, 1994, 39 (06) :387-394

[5] AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy - The Swiss HIV Cohort Study [J].

Ledergerber, B ;

Erard, V ;

Weber, R ;

Hirschel, B ;

Furrer, H ;

Battegay, M ;

Vernazza, P ;

Bernasconi, E ;

Opravil, M ;

Kaufmann, D ;

Sudre, P ;

Francioli, P ;

Telenti, A .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (23) :2220-2226

[6] Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study [J].

Ledergerber, B ;

Egger, M ;

Opravil, M ;

Telenti, A ;

Hirschel, B ;

Battegay, M ;

Vernazza, P ;

Sudre, P ;

Flepp, M ;

Furrer, H ;

Francioli, P ;

Weber, R .

LANCET, 1999, 353 (9156) :863-868

[7] The epidemiology of hepatitis C in a UK health regional population of 5.12 million [J].

Mohsen, AH .

GUT, 2001, 48 (05) :707-713

[8] Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients [J].

Muzzi, A ;

Leandro, G ;

Rubbia-Brandt, L ;

James, R ;

Keiser, O ;

Malinverni, R ;

Dufour, JF ;

Helbling, B ;

Hadengue, A ;

Gonvers, JJ ;

Müllhaupt, B ;

Cerny, A ;

Mondelli, MU ;

Negro, F .

JOURNAL OF HEPATOLOGY, 2005, 42 (01) :41-46

[9]

NAT'L COMM'N ON TERRORIST ATTACKS UPON THE UNITED STATES, 2004, TECHN APPR 75 INT AL

[10] Prognosis of chronic hepatitis C:: Results of a large, prospective cohort study [J].

Niederau, C ;

Lange, S ;

Heintges, T ;

Erhardt, A ;

Buschkamp, M ;

Hürter, D ;

Nawrocki, M ;

Kruska, L ;

Hensel, F ;

Petry, W ;

Häussinger, D .

HEPATOLOGY, 1998, 28 (06) :1687-1695

← 1 2 →